Joanne Wuensch
Stock Analyst at Citi
(3.68)
# 2,147
Out of 5,133 analysts
1301
Total ratings
54.7%
Success rate
2.6%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMRS GMR Solutions | Reiterated: Buy | $15 | $11.54 | +29.98% | 1 | Nov 11, 2026 | |
| IRTC iRhythm Holdings | Downgraded: Hold | $157 → $124 | $91.91 | +34.91% | 59 | Nov 9, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $208 → $241 | $218.03 | +10.54% | 42 | Nov 6, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $123 → $149 | $122.94 | +21.20% | 31 | Nov 6, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | n/a | $20.07 | - | 49 | Nov 6, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 → $117 | $107.15 | +9.19% | 86 | Nov 5, 2026 | |
| PODD Insulet | Reiterated: Hold | $150 → $170 | $152.48 | +11.49% | 48 | Nov 5, 2026 | |
| SGHT Sight Sciences | Reiterated: Hold | n/a | $10.83 | - | 30 | Nov 5, 2026 | |
| WAT Waters | Reiterated: Buy | $470 → $536 | $460.25 | +16.46% | 2 | Nov 4, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Hold | $99 → $117 | $103.21 | +13.36% | 65 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 | $44.34 | -0.77% | 84 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $315 | $309.64 | +1.73% | 62 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $412 → $494 | $416.42 | +18.63% | 2 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $23 | $21.09 | +9.06% | 20 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $71 → $79 | $83.02 | -4.84% | 29 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $247 | $245.72 | +0.52% | 46 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $122 | $108.52 | +12.42% | 90 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $270 | $233.02 | +15.87% | 2 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $14 | $14.40 | -2.78% | 32 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 | $83.33 | +26.01% | 68 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $17.99 | +44.52% | 7 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $443.59 | +12.72% | 38 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $27 | $25.81 | +4.61% | 62 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 → $303 | $285.75 | +6.04% | 64 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $102.86 | +6.94% | 86 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $350 | $320.91 | +9.06% | 44 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $62.65 | -4.23% | 58 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $70.75 | +30.04% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $96 | $126.70 | -24.23% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.15 | $2.86 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 55.96 → CHF 57.64 | CHF 61.36 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $239.53 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.89 | n/a | 2 | Sep 26, 2016 |
GMR Solutions
Nov 11, 2026
Reiterated: Buy
Price Target: $15
Current: $11.54
Upside: +29.98%
iRhythm Holdings
Nov 9, 2026
Downgraded: Hold
Price Target: $157 → $124
Current: $91.91
Upside: +34.91%
Becton, Dickinson and Company
Nov 6, 2026
Reiterated: Buy
Price Target: $208 → $241
Current: $218.03
Upside: +10.54%
Haemonetics
Nov 6, 2026
Reiterated: Buy
Price Target: $123 → $149
Current: $122.94
Upside: +21.20%
Tandem Diabetes Care
Nov 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.07
Upside: -
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $110 → $117
Current: $107.15
Upside: +9.19%
Insulet
Nov 5, 2026
Reiterated: Hold
Price Target: $150 → $170
Current: $152.48
Upside: +11.49%
Sight Sciences
Nov 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $10.83
Upside: -
Waters
Nov 4, 2026
Reiterated: Buy
Price Target: $470 → $536
Current: $460.25
Upside: +16.46%
Zimmer Biomet Holdings
Nov 4, 2026
Rated: Hold
Price Target: $99 → $117
Current: $103.21
Upside: +13.36%
Nov 3, 2026
Rated: Hold
Price Target: $44
Current: $44.34
Upside: -0.77%
Nov 2, 2026
Reiterated: Buy
Price Target: $315
Current: $309.64
Upside: +1.73%
Oct 30, 2026
Reiterated: Buy
Price Target: $412 → $494
Current: $416.42
Upside: +18.63%
Oct 29, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $21.09
Upside: +9.06%
Oct 29, 2026
Reiterated: Hold
Price Target: $71 → $79
Current: $83.02
Upside: -4.84%
Oct 29, 2026
Reiterated: Buy
Price Target: $225 → $247
Current: $245.72
Upside: +0.52%
Oct 22, 2026
Rated: Buy
Price Target: $125 → $122
Current: $108.52
Upside: +12.42%
Oct 22, 2026
Reiterated: Buy
Price Target: $230 → $270
Current: $233.02
Upside: +15.87%
Oct 22, 2026
Rated: Hold
Price Target: $15 → $14
Current: $14.40
Upside: -2.78%
Oct 21, 2026
Reiterated: Buy
Price Target: $105
Current: $83.33
Upside: +26.01%
Oct 21, 2026
Reiterated: Buy
Price Target: $26
Current: $17.99
Upside: +44.52%
Oct 20, 2026
Reiterated: Buy
Price Target: $500
Current: $443.59
Upside: +12.72%
Oct 5, 2026
Reiterated: Hold
Price Target: $28 → $27
Current: $25.81
Upside: +4.61%
Oct 5, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $285.75
Upside: +6.04%
Oct 5, 2026
Reiterated: Buy
Price Target: $110
Current: $102.86
Upside: +6.94%
Oct 5, 2026
Reiterated: Hold
Price Target: $350
Current: $320.91
Upside: +9.06%
Oct 2, 2026
Reiterated: Hold
Price Target: $60
Current: $62.65
Upside: -4.23%
Aug 13, 2026
Upgraded: Buy
Price Target: $92
Current: $70.75
Upside: +30.04%
Jul 8, 2026
Reiterated: Hold
Price Target: $92 → $96
Current: $126.70
Upside: -24.23%
May 23, 2025
Reiterated: Hold
Price Target: $4.15
Current: $2.86
Upside: n/a
Nov 16, 2022
Reiterated: Hold
Price Target: CHF 55.96 → CHF 57.64
Current: CHF 61.36
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $239.53
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $28.89
Upside: n/a